Neurodiagnostics Market Research Reveals Path To $13.47 Billion By 2030

The neurodiagnostics sector is rapidly evolving, driven by technological innovations and rising demand for early and accurate neurological assessments. This industry plays a crucial role in diagnosing and monitoring neurological conditions, and its growth is set to accelerate in the coming years. Let's explore the market size projections, leading players, key trends, and segmentation that define this dynamic field.

Projected Market Size and Growth Outlook for the Neurodiagnostics Industry
The neurodiagnostics market is anticipated to expand significantly, reaching a valuation of $13.48 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 6.5% during the forecast period. Factors contributing to this surge include the rising development of biomarker-based diagnostic techniques, increased investments in neuroimaging technologies, wider adoption of digital neuroinformatics platforms, and the introduction of portable and wearable neurodiagnostic devices. Additionally, demand for point-of-care neurological testing is on the rise. Key trends shaping the market include greater use of advanced neuroimaging tools, expanded application of in-vitro neurodiagnostic biomarkers, emphasis on early detection of neurological diseases, and growing utilization of EEG and MEG for continuous brain monitoring. There is also a stronger focus on minimally invasive and non-invasive diagnostic approaches.

The neurodiagnostics market size has grown strongly in recent years. It will grow from $9.79 billion in 2025 to $10.46 billion in 2026 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to increased incidence of neurological disorders, early adoption of mri and ct scanning, development of eeg and emg systems, rising demand for stroke diagnosis tools, growth in hospital-based neurodiagnostic infrastructure.

Download a free sample of the neurodiagnostics market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20902&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Leading Corporations Driving the Neurodiagnostics Market Forward
Several prominent companies stand out in the neurodiagnostics landscape, including Nihon Kohden Corporation, Cephalon LLC, Stratus Neuro LLC, Cadwell Industries Inc., Compumedics Limited, Ceribell Inc., CND Life Sciences Inc., Lifelines Neuro Inc., ANT Neuro B.V., Neurovative Diagnostics LLC, Firefly Neuroscience Inc., IntraNerve Neuroscience Inc., NeuroDiagnostics Laboratories LLC, Advanced Brain Monitoring Inc., Spes Medica S.r.l., BioSignal Group Inc., Combinostics Inc., Deymed Diagnostic LLC, NeuLine Health Inc., Ridge Diagnostics Inc., Beacon Biosignals Inc., and Intch Inc.

Strategic Acquisition Enhancing Neurodiagnostics Capabilities
In October 2025, Natus Medical Incorporated, a US-based medical technology firm, acquired Norway-based Holberg EEG for an undisclosed sum. This acquisition aims to strengthen Natus Medical's neurodiagnostic portfolio by integrating Holberg's cutting-edge AI-driven EEG interpretation tools. Holberg EEG specializes in artificial intelligence solutions for electroencephalogram analysis, and this merger is expected to improve diagnostic precision and streamline clinical workflows.

View the full neurodiagnostics market report:
https://www.thebusinessresearchcompany.com/report/neurodiagnostics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Technological Innovations Shaping the Neurodiagnostics Industry
Key players in the neurodiagnostics sector are pushing forward with advancements in software algorithms designed to boost diagnostic accuracy and patient care. These sophisticated algorithms utilize artificial intelligence and machine learning to process complex data and enhance decision-making. For example, in October 2023, Ceribell Inc., a US manufacturer of medical equipment, introduced the ClarityPro AI algorithm, a breakthrough in detecting electrographic status epilepticus (ESE). Integrated within the Ceribell EEG system, ClarityPro uses machine learning to interpret EEG signals in real time and alert clinicians to potential seizures. Importantly, this AI-powered tool is the first acute care device to receive FDA clearance for standalone diagnosis, improving clinical efficiency by continuously monitoring brain activity and supporting faster treatment interventions.

Detailed Segmentation and Market Share in the Global Neurodiagnostics Arena
The market for neurodiagnostics is categorized across several dimensions:
1) By Type: Diagnostic and Imaging Solutions, In-Vitro Diagnostics
2) By Technology: Neuroimaging Technologies, Nuclear Medicine Imaging, Near Infrared Spectroscopic Imaging (NIRS), Magneto-Encephalography (MEG), Voxel Based Morphometry (VBM), Neuroinformatics
3) By Condition: Epilepsy, Alzheimer's Disease, Parkinson's Disease, Stroke, Other Conditions
4) By End Use: Hospitals and Clinics, Diagnostic Laboratories, Imaging Centers, Other End Uses

Subcategories within these segments include:
- Diagnostic and Imaging Solutions: MRI (Magnetic Resonance Imaging) Systems, CT (Computed Tomography) Scanners, EEG (Electroencephalogram) Systems, EMG (Electromyography) Systems, MEG (Magnetoencephalography) Systems, PET (Positron Emission Tomography) Scanners, SPECT (Single Photon Emission Computed Tomography) Scanners, Functional MRI (fMRI) Systems, Intracranial Pressure Monitors
- In-Vitro Diagnostics: Blood-Based Diagnostics, Cerebrospinal Fluid (CSF) Analysis, Genetic Testing and Biomarkers, Neurochemical Diagnostics, Point-of-Care Neurodiagnostics, Diagnostic Kits for Neurodegenerative Disorders

This detailed segmentation illustrates the diverse technologies and diagnostic methods that comprise the neurodiagnostics market, highlighting a multifaceted approach to neurological health assessment and management.

New strategic additions in our 2026 market reports include market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.